237 related articles for article (PubMed ID: 16803851)
1. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women.
Kok P; Roelfsema F; Frölich M; van Pelt J; Stokkel MP; Meinders AE; Pijl H
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1038-43. PubMed ID: 16803851
[TBL] [Abstract][Full Text] [Related]
2. Activation of dopamine D2 receptors lowers circadian leptin concentrations in obese women.
Kok P; Roelfsema F; Frölich M; van Pelt J; Meinders AE; Pijl H
J Clin Endocrinol Metab; 2006 Aug; 91(8):3236-40. PubMed ID: 16705078
[TBL] [Abstract][Full Text] [Related]
3. Short-term treatment with bromocriptine improves impaired circadian growth hormone secretion in obese premenopausal women.
Kok P; Roelfsema F; Frölich M; van Pelt J; Meinders AE; Pijl H
J Clin Endocrinol Metab; 2008 Sep; 93(9):3455-61. PubMed ID: 18559918
[TBL] [Abstract][Full Text] [Related]
4. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
[TBL] [Abstract][Full Text] [Related]
5. Basal and insulin-regulated free fatty acid and glucose metabolism in humans.
Shadid S; Kanaley JA; Sheehan MT; Jensen MD
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1770-4. PubMed ID: 17299081
[TBL] [Abstract][Full Text] [Related]
6. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
[TBL] [Abstract][Full Text] [Related]
7. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
Doyon C; Samson P; Lalonde J; Richard D
J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
[TBL] [Abstract][Full Text] [Related]
8. Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans.
Gravholt CH; Dall R; Christiansen JS; Møller N; Schmitz O
Obes Res; 2002 Aug; 10(8):774-81. PubMed ID: 12181386
[TBL] [Abstract][Full Text] [Related]
9. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
[TBL] [Abstract][Full Text] [Related]
10. Fish oil supplementation does not alter energy efficiency in healthy males.
Bortolotti M; Tappy L; Schneiter P
Clin Nutr; 2007 Apr; 26(2):225-30. PubMed ID: 17270317
[TBL] [Abstract][Full Text] [Related]
11. Enhanced circadian ACTH release in obese premenopausal women: reversal by short-term acipimox treatment.
Kok P; Kok SW; Buijs MM; Westenberg JJ; Roelfsema F; Frölich M; Stokkel MP; Meinders AE; Pijl H
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E848-56. PubMed ID: 15280154
[TBL] [Abstract][Full Text] [Related]
12. Time course of increased lipid and decreased glucose oxidation during early phase of childhood obesity.
Le Stunff C; Bougnères PF
Diabetes; 1993 Jul; 42(7):1010-6. PubMed ID: 8513968
[TBL] [Abstract][Full Text] [Related]
13. Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women.
Kamath V; Jones CN; Yip JC; Varasteh BB; Cincotta AH; Reaven GM; Chen YD
Diabetes Care; 1997 Nov; 20(11):1697-701. PubMed ID: 9353611
[TBL] [Abstract][Full Text] [Related]
14. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
[TBL] [Abstract][Full Text] [Related]
15. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
16. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral fat perception by modified sham feeding on energy expenditure, hormones and appetite profile in the postprandial state.
Smeets AJ; Lejeune MP; Westerterp-Plantenga MS
Br J Nutr; 2009 May; 101(9):1360-8. PubMed ID: 18814804
[TBL] [Abstract][Full Text] [Related]
18. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
[TBL] [Abstract][Full Text] [Related]
19. Impaired subcutaneous adipocyte lipogenesis is associated with systemic insulin resistance and increased apolipoprotein B/AI ratio in men and women.
Hoffstedt J; Förster D; Löfgren P
J Intern Med; 2007 Jul; 262(1):131-9. PubMed ID: 17598821
[TBL] [Abstract][Full Text] [Related]
20. Association of the antidiabetic effects of bromocriptine with a shift in the daily rhythm of monoamine metabolism within the suprachiasmatic nuclei of the Syrian hamster.
Luo S; Luo J; Cincotta AH
Chronobiol Int; 2000 Mar; 17(2):155-72. PubMed ID: 10757461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
